KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (Weighted Average) (2016 - 2025)

Edwards Lifesciences has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $584.8 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $584.8 million for Q4 2025, down 2.16% from a year ago — trailing twelve months through Dec 2025 was $584.8 million (down 2.16% YoY), and the annual figure for FY2025 was $584.8 million, down 2.16%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $584.8 million at Edwards Lifesciences, roughly flat from $584.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for EW hit a ceiling of $623.6 million in Q3 2021 and a floor of $584.7 million in Q3 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $606.9 million (2023), compared with a mean of $607.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.24% in 2021 and later decreased 2.51% in 2025.
  • Edwards Lifesciences' Shares Outstanding (Weighted Average) stood at $623.3 million in 2021, then dropped by 0.69% to $619.0 million in 2022, then decreased by 1.99% to $606.7 million in 2023, then dropped by 1.48% to $597.7 million in 2024, then dropped by 2.16% to $584.8 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $584.8 million (Q4 2025), $584.7 million (Q3 2025), and $587.0 million (Q2 2025) per Business Quant data.